Skip to main content
SpringerLink
Log in

Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants

  • Published:
Mammalian Genome Aims and scope Submit manuscript

Abstract

So far, epidemiological studies have been performed to investigate the association of CDKN2A/B rs4977756 polymorphism and glioma risk. However, the results from different studies remain inconsistent. To clarify these conflicts and to quantitatively evaluate the effect of rs4977756 polymorphism on glioma risk, a meta-analysis was conducted using relevant published clinical studies about rs4977756 polymorphisms and glioma risk. Relevant studies concerning the association between rs4977756 polymorphism and risk of glioma were included in this meta-analysis. Odds ratio (OR) and 95 % confidence interval (CI) were calculated under fixed or random effects models when appropriate. Subgroup analyses were performed by race. This meta-analysis included 13 studies with a total of 8129 cases and 15,858 controls. The pooled results showed that there was an obvious association of CDKN2A/B rs4977756 polymorphism with risk of glioma in all four comparison models (dominant model/AG + GG vs. AA: OR = 1.36, 95 %CI = 1.20–1.54, p < 0.01; heterozygote comparison/AG vs. AA: OR = 1.31, 95 %CI = 1.12–1.53, p < 0.01; homozygote comparison/GG versus AA: OR = 1.49, 95 %CI = 1.36–1.64, p < 0.01; additive model/G vs. A: OR = 1.23, 95 %CI = 1.18–1.28, p < 0.01, respectively). For the subgroup analyses of ethnicities, similar results were observed in Caucasians. However, the association was not found between rs4977756 polymorphism and the risk of glioma in all models for the Asian studies. The CDKN2A/B rs4977756 polymorphism is obvious increase the risk of glioma in Caucasians. Future studies are needed to confirm the results in other ethnic populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Ahmed R, Oborski MJ, Hwang M et al (2014) Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods. Cancer Manag Res 6:149–170

    PubMed  CAS  PubMed Central  Google Scholar 

  • Bondy ML, Scheurer ME, Malmer B et al (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113:1953–1968

    Article  PubMed  PubMed Central  Google Scholar 

  • Chen H, Chen Y, Zhao Y et al (2011) Association of sequence variants on chromosomes 20, 11, and 5 (20q13.33, 11q23.3, and 5p15.33) with glioma susceptibility in a Chinese population. Am J Epidemiol 173:915–922

    Article  PubMed  Google Scholar 

  • Di Stefano AL, Enciso-Mora V, Marie Y et al (2013) Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies. Neuro-oncology 15:542–547

    Article  PubMed  PubMed Central  Google Scholar 

  • Dolecek TA, Propp JM, Stroup NE, Kruchko C (2012) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005–2009. Neuro-oncology 14(Suppl 5):v1–v49

    Article  PubMed  PubMed Central  Google Scholar 

  • Dong YS, Hou WG, Li XL et al (2014) Genetic association of CHEK2, GSTP1, and ERCC1 with glioblastoma in the Han Chinese population. Tumour Biol 35:4937–4941

    Article  PubMed  CAS  Google Scholar 

  • Egan KM, Thompson RC, Nabors LB et al (2011) Cancer susceptibility variants and the risk of adult glioma in a US case–control study. J Neurooncol 104:535–542

    Article  PubMed  PubMed Central  Google Scholar 

  • Lachance DH, Yang P, Johnson DR et al (2011) Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. Am J Epidemiol 174:574–581

    Article  PubMed  PubMed Central  Google Scholar 

  • Li S, Jin T, Zhang J et al (2012) Polymorphisms of TREH, IL4R and CCDC26 genes associated with risk of glioma. Cancer Epidemiol 36:283–287

    Article  PubMed  CAS  Google Scholar 

  • Melin B, Dahlin AM, Andersson U et al (2013) Known glioma risk loci are associated with glioma with a family history of brain tumours—a case-control gene association study. Int J Cancer J Int du Cancer 132:2464–2468

    Article  CAS  Google Scholar 

  • Parsons DW, Jones S, Zhang X et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Rajaraman P, Melin BS, Wang Z et al (2012) Genome-wide association study of glioma and meta-analysis. Hum Genet 131:1877–1888

    Article  PubMed  PubMed Central  Google Scholar 

  • Research Cancer Genome Atlas (2008) N. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068

    Article  Google Scholar 

  • Ricard D, Idbaih A, Ducray F et al (2012) Primary brain tumours in adults. Lancet 379:1984–1996

    Article  PubMed  Google Scholar 

  • Safaeian M, Rajaraman P, Hartge P et al (2013) Joint effects between five identified risk variants, allergy, and autoimmune conditions on glioma risk. Cancer Causes Control 24:1885–1891

    Article  PubMed  PubMed Central  Google Scholar 

  • Schoemaker MJ, Robertson L, Wigertz A et al (2010) Interaction between 5 genetic variants and allergy in glioma risk. Am J Epidemiol 171:1165–1173

    Article  PubMed  Google Scholar 

  • Sharpless NE, Bardeesy N, Lee KH et al (2001) Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413:86–91

    Article  PubMed  CAS  Google Scholar 

  • Shete S, Hosking FJ, Robertson LB et al (2009) Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet 41:899–904

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Stroup DF, Berlin JA, Morton SC et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283:2008–2012

    Article  PubMed  CAS  Google Scholar 

  • Wager M, Menei P, Guilhot J et al (2008) Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study. Br J Cancer 98:1830–1838

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Wang SS, Hartge P, Yeager M et al (2011) Joint associations between genetic variants and reproductive factors in glioma risk among women. Am J Epidemiol 174:901–908

    Article  PubMed  PubMed Central  Google Scholar 

  • Wrensch M, Jenkins RB, Chang JS et al (2009) Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility. Nat Genet 41:905–908

    Article  PubMed  CAS  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was generously supported by Grants from the Zhejiang Provincial Natural Science Foundation of China (Grant No. LY13H160003), Zhejiang Provincial Medicines Health Science and Technology Program Foundation of China (Grant No. 2013KYB162 and No. 2015KYB223).

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Sir Run Run Shaw Hospital, College of Medical Sciences, Zhejiang University, Hangzhou, 310016, China

    Xuchen Qi, Yingfeng Wan, Shuxu Yang & Yirong Wang

  2. Department of Reproductive Endocrinology, Women’s Hospital, College of Medical Sciences, Zhejiang University, Hangzhou, 310006, China

    Qitao Zhan

  3. Department of General Surgery, Sir Run Run Shaw Hospital, College of Medical Sciences, Zhejiang University, Hangzhou, 310016, China

    Xiujun Cai

Authors
  1. Xuchen Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yingfeng Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Qitao Zhan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Shuxu Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yirong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xiujun Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiujun Cai.

Ethics declarations

Conflicts of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qi, X., Wan, Y., Zhan, Q. et al. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants. Mamm Genome 27, 1–7 (2016). https://doi.org/10.1007/s00335-015-9612-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00335-015-9612-9

Keywords

Search

Navigation